title: [Impact of synthetic biology on patent law in view of of European jurisprudence].
abstract: The roots of synthetic biology--the redesign of biological molecules, structures and organisms--can be traced to the research developed by Jacques L. Monod and François Jacob in 1961. This field has undergone significant growth in the past ten years and its emergence has raised the question of whether the patent system is suitable to protect inventions in emergent areas as synthetic biology. The article will analyze the numerous scientific, socio-economic, ethical and legal challenges faced by synthetic biology, introducing the European Patent Law related to biotechnology as the minimum common framework and considering if more changes are needed to adequately protect the inventor rights, while taking into account the arrival of a new research culture, characterized by embracing open-innovation and open-source initiatives. The discussion will review some biotechnological patent law cases and summarize questions as whether isolated molecules of DNA are eligible for patent or the patentability of living matter, under the terms of Directive 98/44/EC. The article will finally consider the impact of synthetic biology on the European patent system.
authors.forename: María Angela
authors.initials: MA
authors.lastname: Bernardo Alvarez
mesh_terms: D005060:Europe; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D012106:Research / Q000331:legislation & jurisprudence; D066252:Sociological Factors; D058615:Synthetic Biology / Q000331:legislation & jurisprudence*